For research use only. Not for therapeutic Use.
Alvimopan-D9 is a deuterated form of alvimopan, a peripherally acting opioid receptor antagonist used to treat postoperative ileus. In this compound, nine hydrogen atoms are replaced with deuterium, which enhances its utility in pharmacokinetic and metabolic studies. The deuterium labeling allows for precise tracking in mass spectrometry and NMR spectroscopy, facilitating the study of the drug’s absorption, distribution, metabolism, and excretion. Alvimopan-D9 retains the same therapeutic effects as the non-deuterated version, making it valuable for research and clinical studies.
| Catalog Number | R074759 |
| Synonyms | 2-[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic acid-d9 |
| Molecular Formula | C25H23D9N2O4 |
| Purity | 98% |
| Appearance | White Crystalline Soild |
| Related CAS | 156053-89-3(unlabeled) |
| Analysis method | atom D |
